Drug Type Biosimilar, Hormone |
Synonyms Insulin degludec Biosimilar (BioGenomics Ltd.), Tresiba biosimilar(BioGenomics), 德谷胰岛素生物类似药(BioGenomics Ltd.) |
Target |
Action agonists |
Mechanism INSR agonists(Insulin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 1 | Preclinical | India | 01 Jun 2025 | |
Diabetes Mellitus, Type 2 | Preclinical | India | 01 Jun 2025 |